EndoQuest plans to test its technology on an estimated 50 participants enrolled across five sites in the US. The company’s ...

EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...

EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...

EndoQuest Robotics , a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption (IDE ...

EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption ...

EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery. About EndoQuest Robotics EndoQuest Robotics is a leading innovator in the development of ...

Houston, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies ...

Houston, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery.